Weston County Health Services

29125 APPLICATION OF SHORT ARM SPLINT (FOREARM TO HAND); STA

58160-0890-52 - influenza virus vaccine, inactivated preservative-free quadrivalent Sus [MEMO]

ABDOMINAL PARACENTESIS (DIAGNOSTIC OR THERAPEUTIC); WITH IMAGING GUIDANCE

ABDOMINAL PARACENTESIS (DIAGNOSTIC OR THERAPEUTIC); WITHOUT IMAGING GUIDANCE

ACETYLCYSTEINE 200 MG/ML (20 %) INTRAVENOUS SOLUTION [35100]

ACETYLCYSTEINE, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER GRAM

ACTH STIMULATION PANEL; FOR ADRENAL INSUFFICIENCY THIS PANEL MUST INCLUDE THE FOLLOWING: CORTISOL (82533 X 2)

ACUTE HEPATITIS PANEL THIS PANEL MUST INCLUDE THE FOLLOWING: HEPATITIS A ANTIBODY (HAAB), IGM ANTIBODY (86709) HEPATITIS B CORE ANTIBODY (HBCAB), IGM ANTIBODY (86705) HEPATITIS B SURFACE ANTIGEN (HBSAG) (87340) HEPATITIS C ANTIBODY (86803)

ADRENOCORTICOTROPIC HORMONE (ACTH) LEVEL

AFP TETRA (LCP 017319)(ESTRIOL)

ALBUMIN, HUMAN 25 % INTRAVENOUS SOLUTION

ALBUMIN; URINE (EG, MICROALBUMIN), SEMIQUANTITATIVE (EG, REAGENT STRIP ASSAY)

ALBUTEROL, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE, 1 MG

ALBUTEROL, UP TO 2.5 MG AND IPRATROPIUM BROMIDE, UP TO 0.5 MG, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME

ALCOHOL (ETHANOL); ANY SPECIMEN EXCEPT URINE AND BREATH, IMMUNOASSAY (EG, IA, EIA, ELISA, RIA, EMIT, FPIA) AND ENZYMATIC METHODS (EG, ALCOHOL DEHYDROGENASE)

ALLERGEN SPECIFIC IGE; QUANTITATIVE OR SEMIQUANTITATIVE, CRUDE ALLERGEN EXTRACT, EACH

ALPHA-1-ANTITRYPSIN (PROTEIN) BLOOD TEST, PHENOTYPE

ALTEPLASE 2 MG INTRA-CATHETER SOLUTION [19101]

AMINOPHYLLINE 25 MG/ML INTRAVENOUS SOLUTION (WRAPPED) [4000723]

AMPHOTERICIN B LIPOSOME 50 MG INTRAVENOUS SUSPENSION

AMPICILLIN 500 MG SOLUTION FOR INJECTION [13513]

AMPICILLIN-SULBACTAM 1.5 GRAM SOLUTION FOR INJECTION [14372]

ANALYSIS FOR ANTIBODY (IGM) TO CYTOMEGALOVIRUS (CMV)

ANALYSIS FOR ANTIBODY BORRELIA BURGDORFERI (LYME DISEASE BACTERIA)

ANALYSIS FOR ANTIBODY TO CYTOMEGALOVIRUS (CMV)

ANALYSIS FOR ANTIBODY TO EPSTEIN-BARR VIRUS (MONONUCLEOSIS VIRUS), NUCLEAR ANTIGEN

ANALYSIS FOR ANTIBODY TO EPSTEIN-BARR VIRUS (MONONUCLEOSIS VIRUS), VIRAL CAPSID

ANALYSIS FOR ANTIBODY TO HERPES SIMPLEX VIRUS, TYPE 1

ANALYSIS FOR ANTIBODY TO HERPES SIMPLEX VIRUS, TYPE 2

ANALYSIS FOR ANTIBODY TO HIV-1 AND HIV-2 VIRUS

ANALYSIS FOR ANTIBODY TO HIV-2 VIRUS

ANALYSIS FOR ANTIBODY TO LEGIONELLA (WATERBORNE BACTERIA)

ANALYSIS FOR ANTIBODY TO RUBELLA (GERMAN MEASLES VIRUS)

ANALYSIS FOR ANTIBODY TO VARICELLA-ZOSTER VIRUS (CHICKEN POX)

ANALYSIS USING CHEMILUMINESCENT TECHNIQUE (LIGHT AND CHEMICAL )REACTION

ANES PROPOFOL 10MG/ML 50ML MDV

ANTIBODY IDENTIFICATION, RBC ANTIBODIES, EACH PANEL FOR EACH SERUM TECHNIQUE

ANTIBODY; EPSTEIN-BARR (EB) VIRUS, EARLY ANTIGEN (EA)

ANTIBODY; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (CORONAVIRUS DISEASE [COVID-19])

ANTIDEPRESSANTS NOT OTHERWISE SPECIFIED

ANTIHUMAN GLOBULIN TEST (COOMBS TEST); INDIRECT, EACH ANTIBODY TITER

ANTIHUMAN GLOBULIN TEST (COOMBS TEST); INDIRECT, QUALITATIVE, EACH REAGENT RED CELL

ANTIVENIN (CROTALIDAE) POLYVALENT (ANAVIP) 120MG INJ (G/K)

APPLICATION LONG ARM SPLINT SHOULDER HAN

APPLICATION OF A MODALITY TO 1 OR MORE AREAS; ELECTRICAL STIMULATION (MANUAL), EACH 15 MINUTES

APPLICATION OF A MODALITY TO 1 OR MORE AREAS; ELECTRICAL STIMULATION (UNATTENDED)

APPLICATION OF A MODALITY TO 1 OR MORE AREAS; INFRARED

APPLICATION OF A MODALITY TO 1 OR MORE AREAS; IONTOPHORESIS, EACH 15 MINUTES

APPLICATION OF A MODALITY TO 1 OR MORE AREAS; PARAFFIN BATH

APPLICATION OF A MODALITY TO 1 OR MORE AREAS; TRACTION, MECHANICAL